DENVER, CO – March 7, 2019 – Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it has broken ground on its first Community Clinic and Dispensing Pharmacy for the treatment of diabetes in the Republic of Vanuatu. The company held a groundbreaking event at 11:00 a.m. on March 5 in Erakor Village, Vanuatu where the Paramount Chief welcomed Phoenix Life officials such as Global Head of Security and Transport, Former Police Commissioner John Taleo, Head of National Healthcare, Former Director of Port Vila Central Hospital, the Department of Curative & Hospital Services and Vanuatu’s Ministry of Health, Dr. Santus Wari, and Martin Tindall, Phoenix Life CEO and Founder.
According to the International Diabetes Federation, 1 in 10 Vanuatu citizens are diagnosed with diabetes every year. This is why Denver-based Phoenix Life chose to tackle diabetes in The Republic of Vanuatu, with a focus on addressing the national diabetes epidemic with Phoenix Metabolic, a plant based pharmaceutical, extracted from the cannabis plant and designed to specific manage diabetes and its complications. Phoenix Life intends to deliver programs to make diabetes healthcare more accessible and affordable for national healthcare system providers, such as governments in the developing and least developed nations.
“We appreciate the work that Phoenix Life Sciences International is doing in the Republic of Vanuatu to create a solution for our diabetes epidemic using botanical medicine. We’re sorry we were unable to attend the groundbreaking at Erakor Village but we are very excited for the commencement of Phoenix Life’s national diabetes screening and management program in the upcoming months,” said Vanuatu Minister of Health Hon. Jack Norris Kalmet.
At the event, Dr. Santus Wari gave a speech on the benefits of this clinic and stressed the importance of citizens participating in blood sugar testing to better understand their health. Phoenix Life CEO Martin Tindall explained the company’s plans to open a national network of Phoenix Life Community Clinics and Dispensing Pharmacies over the next year. Further, Tindall explained that Phoenix Life plans to conduct a clinical trials in Vanuatu, to be overseen by leading endocrinologists from Australia and the United States. These double blind randomized clinical trials will be used to prove the efficacy of Phoenix Metabolic as a treatment for diabetes as part of Phoenix Life’s global rollout strategy.
Through this community clinic and future locations, Phoenix Life plans to increase healthcare infrastructure throughout the nation to promote better health. Now at locations around the Island Nation and at the event, Phoenix Life offers complimentary blood sugar screenings to test for diabetes and pre-diabetes in the population. Approximately 400 people were screened at the event. Attendees were served a healthy lunch made of traditional Vanuatu cuisine (Island Kai Kai) and taught about ways to improve their health through clean eating habits.
“Diabetes is a disease that affects millions across the globe and is near to my heart as my family, like so many others, has been affected by it,” said Martin Tindall, CEO of Phoenix Life Sciences International Limited. “The groundbreaking of our first Community Clinic and Dispensing Pharmacy for the treatment of diabetes is an exciting next step for Phoenix Life as we work diligently to carry out our mission of transforming international healthcare.”
The clinic will be the first of a national network of Community Clinics and Dispensing Pharmacies for Phoenix Life and will feature examination rooms, analytical labs, a dispensing pharmacy and other services for the health of the local people. As Phoenix Life continues rolling out its screening program “Sik Suka ? Jekem Ia !”, and a national network of Community Clinics and Dispensing Pharmacies, Phoenix Life invites all Vanuatu citizens to receive free blood sugar screenings and, if applicable, treatment.
To learn more about Phoenix Life Sciences International, please visit: http://phoenixlife.co or for the local Vanuatu website to register for more local information please visit: https://phoenixlife.vu.
About Phoenix Life Sciences International Limited
Phoenix Life Sciences International Limited is an adaptive healthcare solutions company. Our business is to advance research and integrate programs and manufacturing of products that target and treat diabetes, pain, cancer, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. We strive to create partnerships and integrate these programs for human health into communities worldwide as part of our Global Health Initiative.
Information contained in this press release regarding Phoenix Life Sciences International, Limited and its subsidiaries, (the “Companies”) may constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements. The words “plan”, “forecast”, “anticipates”, “estimate”, “project”, “intend”, “expect”, “should”, “believe,” and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to, known and unknown risks, uncertainties and other factors which could cause the Company’s actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company’s filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to the Companies herein are expressly qualified in their entirety by the above-mentioned cautionary statement. The Companies disclaim any obligation to update forward-looking statements contained in this press release, except as may be required by law.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and therefore the products sold by Phoenix Life Sciences International Limited are not available on U.S.
Phoenix Life Sciences International Limited does not sell or distribute any products in the United States that are in violation of the United States Controlled Substances Act (US.CSA). The Company does not grow, sell, or distribute cannabis-based products in the United States and is solely involved with the legal distribution of pharmaceutical products that contain active ingredients derived from the cannabis plant within international markets.
Phone: 1.888.717.5655 or international +1.720.699.7222